December 22, 2022 — Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced that the company has achieved the second milestone under the asset purchase agreement with Medtronic of its left-heart access portfolio with the submission for CE Mark of this portfolio under Eur

December 22, 2022 — New research findings have revealed an underlying genetic cause for why some children who have had COVID-19 infection develop Multisystem Inflammatory Syndrome in Children (MIS-C), a rare but potentially life-threatening disease.

December 21, 2022 — Stereotaxis, a global leader in robotic technologies for the treatment of cardiac arrhythmias, announced the successful treatment of patients using the latest Genesis Robotic Magnetic Navigation (RMN) system by physicians of the nationally recognized Fred & Lena Meijer Heart Center, part of Corewell Healt


The U.S.



Late-breaking clinical trials for the American College of Cardiology’s Annual Scientific Session Together with World Congress of Cardiology (ACC.23/WCC) have been announced. ACC.23/WCC will take place March 4-6, 2023, at the Ernets N. Morial Convention Center in New Orleans.


State-of-the-Art Echocardiography

December 19, 2022 —  Anumana, Inc., an AI-driven health technology company and portfolio company of 

December 19, 2022 —  As a leader in vascular care, Delray Medical Center is the first hospital in Florida to acquire the Viz Vascular Suite.  This is a comprehensive software its vascular care team can use to detect disease, optimize workflow, and coordinate care.  The Viz Vascular Suite uses artificial intelligence (AI) to automatically detect suspected pulmonary embolism, right/left ventricle dilation, aortic dissection, and abd

Subscribe Now